2.0
9 June 2025
Current employee
Boston, MA
Recommend
CEO approval
Business outlook
Pros
Best products from a clinical perspective for patient outcomes
Cons
Leadership has made a mess of the company. No strategic plan to grow within the market. No new innovations. Backorders are horrible.